KING Financial Statements From 2010 to 2024
KING PHARMACEUTICALS financial statements provide useful quarterly and yearly information to potential KING PHARMACEUTICALS INC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on KING PHARMACEUTICALS financial statements helps investors assess KING PHARMACEUTICALS's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting KING PHARMACEUTICALS's valuation are summarized below:KING PHARMACEUTICALS INC does not now have any fundamental ratios for analysis.
This module can also supplement various KING PHARMACEUTICALS Technical models . Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Check KING PHARMACEUTICALS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among KING main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . KING financial statements analysis is a perfect complement when working with KING PHARMACEUTICALS Valuation or Volatility modules.
KING |
KING PHARMACEUTICALS INC Company Profit Margin Analysis
KING PHARMACEUTICALS's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current KING PHARMACEUTICALS Profit Margin | 0.05 % |
Most of KING PHARMACEUTICALS's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, KING PHARMACEUTICALS INC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, KING PHARMACEUTICALS INC has a Profit Margin of 0.052%. This is much higher than that of the sector and significantly higher than that of the Pharmaceutical Products industry. The profit margin for all United States stocks is notably lower than that of the firm.
KING PHARMACEUTICALS INC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining KING PHARMACEUTICALS's current stock value. Our valuation model uses many indicators to compare KING PHARMACEUTICALS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across KING PHARMACEUTICALS competition to find correlations between indicators driving KING PHARMACEUTICALS's intrinsic value. More Info.KING PHARMACEUTICALS INC is currently regarded as number one stock in return on asset category among related companies. It is currently regarded as number one stock in profit margin category among related companies fabricating about 2.00 of Profit Margin per Return On Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value KING PHARMACEUTICALS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for KING PHARMACEUTICALS's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the KING PHARMACEUTICALS's earnings, one of the primary drivers of an investment's value.Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the KING PHARMACEUTICALS INC information on this page should be used as a complementary analysis to other KING PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in KING Stock
If you are still planning to invest in KING PHARMACEUTICALS INC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the KING PHARMACEUTICALS's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |